Connection

Terry Day to Humans

Back to Details
This is a "connection" page, showing publications Terry Day has written about Humans.
Terry Day
Connection Strength
1.668
Humans
  1. Trismus intra-operative release and expansion (TIRE): A novel operative treatment for trismus. Head Neck. 2023 03; 45(3):578-585.
    View in: PubMed
    Score: 0.033
  2. Reply to Letter to the Editor regarding "Occult nodal metastasis rate in salivary malignancies". Head Neck. 2022 07; 44(7):1749-1750.
    View in: PubMed
    Score: 0.031
  3. Endocrine mucin-producing sweat gland carcinoma: a systematic review and meta-analysis. J Dermatolog Treat. 2022 Jun; 33(4):2182-2191.
    View in: PubMed
    Score: 0.031
  4. Elective neck dissection in salivary gland malignancies: Systematic review and meta-analysis. Head Neck. 2022 02; 44(2):505-517.
    View in: PubMed
    Score: 0.031
  5. Immune Checkpoint Inhibitors for Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-Analysis. Target Oncol. 2021 11; 16(6):743-752.
    View in: PubMed
    Score: 0.030
  6. Sebaceous Carcinoma of the Eyelid: A Systematic Review and Meta-Analysis. Dermatol Surg. 2021 01 01; 47(1):104-110.
    View in: PubMed
    Score: 0.029
  7. Intraoperative vasopressors in head and neck free flap reconstruction. Microsurgery. 2021 Jan; 41(1):5-13.
    View in: PubMed
    Score: 0.028
  8. Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis. Endocrine. 2021 04; 72(1):27-39.
    View in: PubMed
    Score: 0.028
  9. Endocrine Mucin-Producing Sweat Gland Carcinoma of the Eyelid With Locoregional Metastasis to the Parotid Gland. Dermatol Surg. 2020 08; 46(8):1116-1118.
    View in: PubMed
    Score: 0.028
  10. Predictive value of computed tomography in identifying extranodal extension in human papillomavirus-positive versus human papillomavirus-negative head and neck cancer. Head Neck. 2020 09; 42(9):2687-2695.
    View in: PubMed
    Score: 0.028
  11. Grading systems of oral cavity pre-malignancy: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2020 Nov; 277(11):2967-2976.
    View in: PubMed
    Score: 0.028
  12. Tracheostomy protocols during COVID-19 pandemic. Head Neck. 2020 06; 42(6):1297-1302.
    View in: PubMed
    Score: 0.027
  13. Head and neck cancer care in the COVID-19 pandemic: A brief update. Oral Oncol. 2020 06; 105:104738.
    View in: PubMed
    Score: 0.027
  14. Impact of PD-L1 expression and human papillomavirus status in anti-PD1/PDL1 immunotherapy for head and neck squamous cell carcinoma-Systematic review and meta-analysis. Head Neck. 2020 04; 42(4):774-786.
    View in: PubMed
    Score: 0.027
  15. Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2019 02 01; 145(2):166-177.
    View in: PubMed
    Score: 0.025
  16. Evaluation of a survivorship needs assessment planning tool for head and neck cancer survivor-caregiver dyads. J Cancer Surviv. 2019 02; 13(1):117-129.
    View in: PubMed
    Score: 0.025
  17. Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial. Clin Cancer Res. 2019 02 15; 25(4):1156-1164.
    View in: PubMed
    Score: 0.025
  18. Comparison of psychosocial factors over time among HPV+ oropharyngeal cancer and tobacco-related oral cavity cancer patients. Am J Otolaryngol. 2019 Jan - Feb; 40(1):40-45.
    View in: PubMed
    Score: 0.024
  19. Outcomes and prognostic factors for parotid acinic cell Carcinoma: A National Cancer Database study of 2362 cases. Oral Oncol. 2018 07; 82:53-60.
    View in: PubMed
    Score: 0.024
  20. Preoperative predictors of occult nodal disease in cT1N0 oral cavity squamous cell carcinoma: Review of 2623 cases. Head Neck. 2018 09; 40(9):1967-1976.
    View in: PubMed
    Score: 0.024
  21. Hypermetabolic Vocal Cord Focus With Recurrent Oral Cancer History. JAMA Oncol. 2018 Feb 01; 4(2):248-249.
    View in: PubMed
    Score: 0.023
  22. Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer. Otolaryngol Head Neck Surg. 2018 04; 158(4):649-659.
    View in: PubMed
    Score: 0.023
  23. Predictors of contralateral-bilateral nodal disease in oropharyngeal cancer: A National Cancer Data Base Study. Head Neck. 2018 02; 40(2):338-348.
    View in: PubMed
    Score: 0.023
  24. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer. Cancer. 2017 Dec 15; 123(24):4841-4850.
    View in: PubMed
    Score: 0.023
  25. Clinical features of ectomesenchymal chondromyxoid tumors: A systematic review of the literature. Oral Oncol. 2017 04; 67:192-197.
    View in: PubMed
    Score: 0.022
  26. Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer. Cancer. 2017 Jul 15; 123(14):2651-2660.
    View in: PubMed
    Score: 0.022
  27. Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base. Cancer. 2017 Jun 15; 123(12):2248-2257.
    View in: PubMed
    Score: 0.022
  28. Double paddle ulnar perforator free flap in reconstruction of through-and-through and fistulous defects of the head and neck. Laryngoscope. 2017 06; 127(6):1302-1305.
    View in: PubMed
    Score: 0.022
  29. Risk Factors Associated With Unplanned Readmission in Patients Undergoing Parotid Cancer Surgery: A Study of the National Cancer Database. JAMA Otolaryngol Head Neck Surg. 2016 06 01; 142(6):544-50.
    View in: PubMed
    Score: 0.021
  30. Predictors of survival in parotid adenocarcinoma not otherwise specified: a National Cancer Database study of 3155 patients. Head Neck. 2016 08; 38(8):1208-12.
    View in: PubMed
    Score: 0.021
  31. Quality of Life in Head and Neck Cancer Patient-Caregiver Dyads: A Systematic Review. Cancer Nurs. 2016 May-Jun; 39(3):238-50.
    View in: PubMed
    Score: 0.021
  32. Prognostic Factors in Myoepithelial Carcinoma of the Major Salivary Glands. Otolaryngol Head Neck Surg. 2016 06; 154(6):1047-53.
    View in: PubMed
    Score: 0.021
  33. Benign Parotid Tumors. Otolaryngol Clin North Am. 2016 Apr; 49(2):327-42.
    View in: PubMed
    Score: 0.021
  34. Rapidly Growing Lateral Neck Mass. JAMA Otolaryngol Head Neck Surg. 2016 Feb; 142(2):185-6.
    View in: PubMed
    Score: 0.020
  35. Intraoperative goal-directed hemodynamic management in free tissue transfer for head and neck cancer. Head Neck. 2016 04; 38 Suppl 1:E1974-80.
    View in: PubMed
    Score: 0.020
  36. Lymphoepithelial carcinoma of the major salivary glands: Predictors of survival in a non-endemic region. Oral Oncol. 2016 Jan; 52:24-9.
    View in: PubMed
    Score: 0.020
  37. Predictors of Nodal Metastasis in Parotid Malignancies: A National Cancer Data Base Study of 22,653 Patients. Otolaryngol Head Neck Surg. 2016 Jan; 154(1):121-30.
    View in: PubMed
    Score: 0.020
  38. Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). Oral Oncol. 2015 Aug; 51(8):727-30.
    View in: PubMed
    Score: 0.020
  39. Melanotic Neuroectodermal Tumor of Infancy: A Systematic Review. J Oral Maxillofac Surg. 2015 Oct; 73(10):1946-56.
    View in: PubMed
    Score: 0.019
  40. Hyperbaric oxygen therapy for the treatment of radiation-induced xerostomia: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Jul; 120(1):22-8.
    View in: PubMed
    Score: 0.019
  41. The ultimate constant of head and neck oncology?the physician-patient relationship. JAMA Otolaryngol Head Neck Surg. 2014 Dec; 140(12):1218-24.
    View in: PubMed
    Score: 0.019
  42. Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014 May; 140(5):441-7.
    View in: PubMed
    Score: 0.018
  43. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014 Apr; 140(4):331-7.
    View in: PubMed
    Score: 0.018
  44. Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 May; 117(5):595-607.
    View in: PubMed
    Score: 0.018
  45. The association between T-stage and clinical nodal metastasis In HPV-positive oropharyngeal cancer. Am J Otolaryngol. 2014 Jul-Aug; 35(4):463-8.
    View in: PubMed
    Score: 0.018
  46. Salivary gland transfer to prevent radiation-induced xerostomia: a systematic review and meta-analysis. Oral Oncol. 2014 Feb; 50(2):77-83.
    View in: PubMed
    Score: 0.017
  47. Well differentiated thyroid carcinoma: current treatment. Curr Treat Options Oncol. 2012 Mar; 13(1):47-57.
    View in: PubMed
    Score: 0.016
  48. mTOR inhibitors and its role in the treatment of head and neck squamous cell carcinoma. Curr Treat Options Oncol. 2012 Mar; 13(1):71-81.
    View in: PubMed
    Score: 0.016
  49. Oromandibular reconstruction. Clin Anat. 2012 Jan; 25(1):108-19.
    View in: PubMed
    Score: 0.015
  50. Oral cancer preventive practices of South Carolina dentists and physicians. J Cancer Educ. 2010 Jun; 25(2):166-73.
    View in: PubMed
    Score: 0.014
  51. Ascending and plunging ranula in a pediatric patient. Otolaryngol Head Neck Surg. 2009 Jun; 140(6):948-9.
    View in: PubMed
    Score: 0.013
  52. Autocrine motility-stimulatory pathways of oral premalignant lesion cells. Clin Exp Metastasis. 2007; 24(2):131-9.
    View in: PubMed
    Score: 0.011
  53. Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users. Arch Otolaryngol Head Neck Surg. 2007 Jan; 133(1):28-31.
    View in: PubMed
    Score: 0.011
  54. Oral premalignant lesions induce immune reactivity to both premalignant oral lesions and head and neck squamous cell carcinoma. Cancer Immunol Immunother. 2007 Jul; 56(7):1077-86.
    View in: PubMed
    Score: 0.011
  55. Endoscopic resection of sinonasal hemangiomas and hemangiopericytomas. ORL J Otorhinolaryngol Relat Spec. 2006; 68(2):69-72.
    View in: PubMed
    Score: 0.010
  56. The use of temporal polyethylene implant after temporalis myofascial flap transposition: clinical and radiographic results from its use in 21 patients. J Oral Maxillofac Surg. 2006 Jan; 64(1):12-22.
    View in: PubMed
    Score: 0.010
  57. Opinions of South Carolina dental students toward tobacco use interventions. J Public Health Dent. 2006; 66(1):44-8.
    View in: PubMed
    Score: 0.010
  58. Prevention of head and neck cancer. Curr Oncol Rep. 2005 Mar; 7(2):145-53.
    View in: PubMed
    Score: 0.010
  59. Assessing oral cancer knowledge among dental students in South Carolina. J Am Dent Assoc. 2005 Mar; 136(3):373-8.
    View in: PubMed
    Score: 0.010
  60. Management of paranasal sinus malignancy. Curr Treat Options Oncol. 2005 Jan; 6(1):3-18.
    View in: PubMed
    Score: 0.009
  61. Melanoma of the head and neck. Curr Treat Options Oncol. 2005 Jan; 6(1):19-30.
    View in: PubMed
    Score: 0.009
  62. Oral cancer knowledge and experience: a survey of South Carolina medical students in 2002. J Cancer Educ. 2005; 20(3):136-42.
    View in: PubMed
    Score: 0.009
  63. Salivary gland neoplasms. Curr Treat Options Oncol. 2004 Feb; 5(1):11-26.
    View in: PubMed
    Score: 0.009
  64. Oral cancer treatment. Curr Treat Options Oncol. 2003 02; 4(1):27-41.
    View in: PubMed
    Score: 0.008
  65. Multinodular goiter. Otolaryngol Clin North Am. 2003 Feb; 36(1):35-54.
    View in: PubMed
    Score: 0.008
  66. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002 Jul-Aug; 52(4):195-215.
    View in: PubMed
    Score: 0.008
  67. Safety of microvascular free tissue transfer reconstruction of the head and neck in the setting of chronic pharmacologic immunosuppression. Head Neck. 2022 07; 44(7):1520-1527.
    View in: PubMed
    Score: 0.008
  68. Systematic review of neuroendocrine carcinomas of the oropharynx. Head Neck. 2022 07; 44(7):1725-1736.
    View in: PubMed
    Score: 0.008
  69. Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
    View in: PubMed
    Score: 0.008
  70. Scapular free flap reconstruction of pharyngoesophageal defects. Clin Otolaryngol. 2021 09; 46(5):1110-1113.
    View in: PubMed
    Score: 0.007
  71. A 2020 Update on Public Awareness of Head and Neck Cancers. Otolaryngol Head Neck Surg. 2022 02; 166(2):305-312.
    View in: PubMed
    Score: 0.007
  72. Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer. JCO Oncol Pract. 2021 10; 17(10):e1512-e1523.
    View in: PubMed
    Score: 0.007
  73. Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation. Otolaryngol Head Neck Surg. 2021 10; 165(4):536-549.
    View in: PubMed
    Score: 0.007
  74. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2020 12 01; 146(12):1109-1119.
    View in: PubMed
    Score: 0.007
  75. Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer. JCO Oncol Pract. 2020 12; 16(12):e1417-e1432.
    View in: PubMed
    Score: 0.007
  76. Free Flap Inset Techniques in Salvage Laryngopharyngectomy Repair: Impact on Fistula Formation and Function. Laryngoscope. 2021 03; 131(3):E875-E881.
    View in: PubMed
    Score: 0.007
  77. Validation of a Novel, Multidomain Head and Neck Cancer Appearance- and Function-Distress Patient-Reported Outcome Measure. Otolaryngol Head Neck Surg. 2020 11; 163(5):979-985.
    View in: PubMed
    Score: 0.007
  78. The role of head and neck cancer advocacy organizations during the COVID-19 pandemic. Head Neck. 2020 Jul; 42(7):1526-1532.
    View in: PubMed
    Score: 0.007
  79. Evaluation of a novel telemedicine-based intervention to manage body image disturbance in head and neck cancer survivors. Psychooncology. 2020 12; 29(12):1988-1994.
    View in: PubMed
    Score: 0.007
  80. Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 05 01; 146(5):455-464.
    View in: PubMed
    Score: 0.007
  81. Association of Medicaid Expansion Under the Affordable Care Act With Stage at Diagnosis and Time to Treatment Initiation for Patients With Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 03 01; 146(3):247-255.
    View in: PubMed
    Score: 0.007
  82. Temporal Trajectory of Body Image Disturbance in Patients with Surgically Treated Head and Neck Cancer. Otolaryngol Head Neck Surg. 2020 03; 162(3):304-312.
    View in: PubMed
    Score: 0.007
  83. Targeting mTOR in Head and Neck Cancer-Response. Clin Cancer Res. 2019 11 01; 25(21):6555.
    View in: PubMed
    Score: 0.007
  84. Prognostic factors associated with achieving total oral diet following osteocutaneous microvascular free tissue transfer reconstruction of the oral cavity. Oral Oncol. 2019 11; 98:1-7.
    View in: PubMed
    Score: 0.007
  85. Body Image Disturbance in Surgically Treated Head and Neck Cancer Patients: A Patient-Centered Approach. Otolaryngol Head Neck Surg. 2019 08; 161(2):278-287.
    View in: PubMed
    Score: 0.006
  86. Prognostic factors associated with achieving total oral diet after glossectomy with microvascular free tissue transfer reconstruction. Oral Oncol. 2019 05; 92:59-66.
    View in: PubMed
    Score: 0.006
  87. Immune Evasion by Head and Neck Cancer: Foundations for Combination Therapy. Trends Cancer. 2019 04; 5(4):208-232.
    View in: PubMed
    Score: 0.006
  88. Body Image Disturbance in Surgically Treated Head and Neck Cancer Patients: A Prospective Cohort Pilot Study. Otolaryngol Head Neck Surg. 2019 07; 161(1):105-110.
    View in: PubMed
    Score: 0.006
  89. A Systematic Review of Patient-Reported Outcome Measures Assessing Body Image Disturbance in Patients with Head and Neck Cancer. Otolaryngol Head Neck Surg. 2019 06; 160(6):941-954.
    View in: PubMed
    Score: 0.006
  90. Factors associated with gastrostomy tube dependence following salvage total laryngectomy with microvascular free tissue transfer. Head Neck. 2019 04; 41(4):865-870.
    View in: PubMed
    Score: 0.006
  91. Prognostic Impact of High-Risk Pathologic Features in HPV-Related Oropharyngeal Squamous Cell Carcinoma and Tobacco Use. Otolaryngol Head Neck Surg. 2019 05; 160(5):855-861.
    View in: PubMed
    Score: 0.006
  92. Causal attributions and their impact on psychosocial functioning in head and neck cancer patient-caregiver dyads: a preliminary, longitudinal study. Qual Life Res. 2019 Apr; 28(4):1105-1109.
    View in: PubMed
    Score: 0.006
  93. Association of Care Processes With Timely, Equitable Postoperative Radiotherapy in Patients With Surgically Treated Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2018 12 01; 144(12):1105-1114.
    View in: PubMed
    Score: 0.006
  94. Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival. Cancer. 2018 08 01; 124(15):3181-3191.
    View in: PubMed
    Score: 0.006
  95. Swallowing Outcomes in Elderly Patients following Microvascular Reconstruction of the Head and Neck. Otolaryngol Head Neck Surg. 2018 08; 159(2):320-327.
    View in: PubMed
    Score: 0.006
  96. Thirty-day readmission in patients undergoing head and neck microvascular reconstruction. Head Neck. 2018 07; 40(7):1366-1374.
    View in: PubMed
    Score: 0.006
  97. Extracapsular Dissection vs Superficial Parotidectomy of Benign Parotid Lesions: Surgical Outcomes and Cost-effectiveness Analysis. JAMA Otolaryngol Head Neck Surg. 2017 11 01; 143(11):1092-1097.
    View in: PubMed
    Score: 0.006
  98. Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: An analysis of the National Cancer Database. Oral Oncol. 2017 09; 72:174-178.
    View in: PubMed
    Score: 0.006
  99. Physical and emotional well-being and support in newly diagnosed head and neck cancer patient-caregiver dyads. J Psychosoc Oncol. 2017 Nov-Dec; 35(6):646-665.
    View in: PubMed
    Score: 0.006
  100. Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1068-74.
    View in: PubMed
    Score: 0.005
  101. Oral cavity and oropharyngeal squamous cell carcinoma--an update. CA Cancer J Clin. 2015 Sep-Oct; 65(5):401-21.
    View in: PubMed
    Score: 0.005
  102. The Validity of Self-reported Recent Smoking in Head and Neck Cancer Surgical Patients. Otolaryngol Head Neck Surg. 2015 Dec; 153(6):990-995.
    View in: PubMed
    Score: 0.005
  103. Tobacco use and surgical outcomes in patients with head and neck cancer. Head Neck. 2016 May; 38(5):700-6.
    View in: PubMed
    Score: 0.005
  104. Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma. J Hematol Oncol. 2014 Sep 27; 7:65.
    View in: PubMed
    Score: 0.005
  105. Perioperative survival of elderly head and neck squamous cell carcinoma patients. Laryngoscope. 2014 Oct; 124(10):2281-6.
    View in: PubMed
    Score: 0.005
  106. Adjunctive diagnostic techniques for oral lesions of unknown malignant potential: Systematic review with meta-analysis. Head Neck. 2015 May; 37(5):755-62.
    View in: PubMed
    Score: 0.005
  107. Thyroid disease and compressive symptoms. Laryngoscope. 2012 Jan; 122(1):13-6.
    View in: PubMed
    Score: 0.004
  108. Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C18-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. 2011 Sep 15; 17(18):6097-105.
    View in: PubMed
    Score: 0.004
  109. Neural outcomes after plasma knife dissection: a pathologic study and clinical correlation. Head Neck. 2010 Oct; 32(10):1321-7.
    View in: PubMed
    Score: 0.004
  110. Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma. Hum Immunol. 2010 Jul; 71(7):659-65.
    View in: PubMed
    Score: 0.003
  111. Respiratory-swallow phase patterns and their relationship to swallowing impairment in patients treated for oropharyngeal cancer. Head Neck. 2010 Apr; 32(4):481-9.
    View in: PubMed
    Score: 0.003
  112. Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer. Laryngoscope. 2010 Feb; 120(2):236-42.
    View in: PubMed
    Score: 0.003
  113. PET/CT in the assessment of previously treated skull base malignancies. Head Neck. 2010 Jan; 32(1):76-84.
    View in: PubMed
    Score: 0.003
  114. Effectiveness of calcium hydroxylapatite paste in vocal rehabilitation. Ann Otol Rhinol Laryngol. 2009 Aug; 118(8):546-51.
    View in: PubMed
    Score: 0.003
  115. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers. Head Neck. 2009 Apr; 31(4):493-502.
    View in: PubMed
    Score: 0.003
  116. Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions. Hum Immunol. 2009 Jun; 70(6):375-82.
    View in: PubMed
    Score: 0.003
  117. 1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells. Otolaryngol Head Neck Surg. 2009 Feb; 140(2):235-40.
    View in: PubMed
    Score: 0.003
  118. Human papillomavirus and head and neck cancer: a growing concern. J S C Med Assoc. 2008 Dec; 104(8):247-51.
    View in: PubMed
    Score: 0.003
  119. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys. 2009 Apr 01; 73(5):1313-8.
    View in: PubMed
    Score: 0.003
  120. Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope. 2008 Jul; 118(7):1180-5.
    View in: PubMed
    Score: 0.003
  121. Proximal esophageal stenosis in head and neck cancer patients after total laryngectomy and radiation. ORL J Otorhinolaryngol Relat Spec. 2008; 70(4):229-35.
    View in: PubMed
    Score: 0.003
  122. Radiation dose, driving performance, and cognitive function in patients with head and neck cancer. Radiother Oncol. 2008 May; 87(2):304-7.
    View in: PubMed
    Score: 0.003
  123. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008 May; 134(5):536-8.
    View in: PubMed
    Score: 0.003
  124. Cranial neuropathy as a presenting sign of recurrent aggressive skin cancer. Dermatol Surg. 2008 Apr; 34(4):483-97.
    View in: PubMed
    Score: 0.003
  125. Use of the OSCE to evaluate brief communication skills training for dental students. J Dent Educ. 2007 Sep; 71(9):1203-9.
    View in: PubMed
    Score: 0.003
  126. Driving performance in patients with cancer in the head and neck region: a pilot study. Arch Otolaryngol Head Neck Surg. 2007 Sep; 133(9):904-9.
    View in: PubMed
    Score: 0.003
  127. Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis. Cancer Lett. 2007 Oct 18; 256(1):101-11.
    View in: PubMed
    Score: 0.003
  128. Driving behaviors in patients with head and neck cancer during and after cancer treatment: a preliminary report. Head Neck. 2007 Jul; 29(7):675-81.
    View in: PubMed
    Score: 0.003
  129. Mechanisms of tumor growth and metastasis in head and neck squamous cell carcinoma. Curr Treat Options Oncol. 2007 Jun; 8(3):227-38.
    View in: PubMed
    Score: 0.003
  130. Anaplastic thyroid carcinoma: an overview. Curr Oncol Rep. 2007 Mar; 9(2):152-8.
    View in: PubMed
    Score: 0.003
  131. Role of mitomycin in upper digestive tract stricture. Head Neck. 2007 Jan; 29(1):12-7.
    View in: PubMed
    Score: 0.003
  132. Oral cancer prevention and early detection: using the PRECEDE-PROCEED framework to guide the training of health professional students. J Cancer Educ. 2007; 22(4):250-3.
    View in: PubMed
    Score: 0.003
  133. Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma. Cancer Lett. 2007 Apr 18; 248(2):269-79.
    View in: PubMed
    Score: 0.003
  134. Muscle-sparing abdominal free flaps in head and neck reconstruction. Head Neck. 2006 Sep; 28(9):802-7.
    View in: PubMed
    Score: 0.003
  135. Head and neck cancer disparities in South Carolina: descriptive epidemiology, early detection, and special programs. J S C Med Assoc. 2006 Aug; 102(7):192-200.
    View in: PubMed
    Score: 0.003
  136. Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo. J Pharmacol Exp Ther. 2006 Jun; 317(3):1188-99.
    View in: PubMed
    Score: 0.003
  137. IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma. Biochem Biophys Res Commun. 2006 Apr 14; 342(3):851-8.
    View in: PubMed
    Score: 0.003
  138. Pediatric rhabdomyosarcoma of the head and neck. Curr Treat Options Oncol. 2006 Jan; 7(1):13-22.
    View in: PubMed
    Score: 0.003
  139. Clinical implications of continued alcohol consumption after diagnosis of upper aerodigestive tract cancer. Alcohol Alcohol. 2006 Mar-Apr; 41(2):140-2.
    View in: PubMed
    Score: 0.003
  140. Laryngeal penetration and aspiration during swallowing after the treatment of advanced oropharyngeal cancer. Arch Otolaryngol Head Neck Surg. 2005 Jul; 131(7):615-9.
    View in: PubMed
    Score: 0.002
  141. Overview of the management of differentiated thyroid cancer. Curr Treat Options Oncol. 2005 Jan; 6(1):47-57.
    View in: PubMed
    Score: 0.002
  142. Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells. Otolaryngol Head Neck Surg. 2005 Jan; 132(1):55-62.
    View in: PubMed
    Score: 0.002
  143. Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J Biol Chem. 2004 Oct 22; 279(43):44311-9.
    View in: PubMed
    Score: 0.002
  144. Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope. 2004 Aug; 114(8):1362-7.
    View in: PubMed
    Score: 0.002
  145. Referred otalgia in head and neck cancer: a unifying schema. Am J Clin Oncol. 2003 Oct; 26(5):e157-62.
    View in: PubMed
    Score: 0.002
  146. Use of P-32 in stage III epithelial carcinoma of the ovary. Gynecol Oncol. 1994 Jul; 54(1):35-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.